New Jersey S 983: Establishes Prescription Drug Review Commission; requires production costs be reported for certain prescription drugs.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2018-01-16)

State: New Jersey · Session: 218 · Bill: S 983

Subjects: COMMISSIONS, PHARMACEUTIC

Sponsors: Cryan, Joseph P., Vitale, Joseph F.

View New Jersey S 983 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.